News

Athena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension

March 3, 2022

Athena Bioscience Cardiovascular Product Portfolio to be Promoted by Sabal Therapeutics

February 22, 2022